Dupont Capital Management Corp Pliant Therapeutics, Inc. Transaction History

Dupont Capital Management Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 30, 2021	SELL	$28.05 - $37.69 $388,492 - $522,006	-13,850 Closed	0 $0
Q1 2021 Apr 29, 2021	BUY	$24.52 - $40.23 $48,328 - $79,293	1,971 Added 16.59%	13,850 $545,000
Q4 2020 Jan 28, 2021	SELL	$19.89 - $32.99 $7,697 - $12,767	-387 Reduced 3.16%	11,879 $270,000
Q3 2020 Oct 29, 2020	BUY	$21.54 - $29.53 $264,209 - $362,214	12,266 New	12,266 $278,000

168

63.2M

245K

373K

Ticker PLRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,682,000
Market Cap $600M
Description
Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

Stay updated on Dupont Capital Management Corp with notifications on news.